Drugs Online |
 |
 | ||
|
Saaz DS Azulfidine |
|
| ||
Drugs Online » Prescription Drugs 14 » Saaz DS Azulfidine Sulfasalazine is used to treat bowel inflammation diarrhea (stool frequency) rectal bleeding and abdominal pain in patients with ulcerative colitis a condition in which the bowel is inflamed. Sulfasalazine delayed-release (Azulfidine EN-tabs) is also used to treat rheumatoid arthritis in adults and children whose disease has not responded well to other medications. Sulfasalazine is in a class of medications called anti-inflammatory drugs. It works by reducing inflammation (swelling) inside the body. Buy Saaz DS Azulfidine and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About Saaz DS Azulfidine: Product Type: Prescription Drugs 14 Saaz DS (Azulfidine Generic Sulfasalazine) Saaz DS (Azulfidine Generic Sulfasalazine) Azulfidine Generic Sulfasalazine 1gm Azulfidine Generic Sulfasalazine Saaz DS
View more Prescription Drugs 14 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
